Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies.

C Harrington, M James, C Wynne

Department of Radiation Oncology, Christchurch Hospital, Christchurch, New Zealand. chris.harrington@cdhb.govt.nz

Clinical oncology (Royal College of Radiologists (Great Britain)) 2010 Sep

filter terms:

A 55 year old man was treated with 36 Gy in 12 fractions palliative chest irradiation for squamous cell carcinoma of the lung. This was followed by 3 cycles of cisplatin and gemcitabine. Five months later he developed clinical and imaging findings consistent with radiation myelopathy. The maximum spinal cord dose was 38.9 Gy. The possible contributions of portal imaging and gemcitabine are discussed and the literature reviewed. Copyright (c) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Citation

C Harrington, M James, C Wynne. Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies. Clinical oncology (Royal College of Radiologists (Great Britain)). 2010 Sep;22(7):561-3